Literature DB >> 19244275

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.

Oliver J Brand1, Jeffrey C Barrett, Matthew J Simmonds, Paul R Newby, Christopher J McCabe, Christopher K Bruce, Boris Kysela, Jackie D Carr-Smith, Thomas Brix, Penny J Hunt, Wilmar M Wiersinga, Laszlo Hegedüs, John Connell, John A H Wass, Jayne A Franklyn, Anthony P Weetman, Joanne M Heward, Stephen C L Gough.   

Abstract

Graves' disease (GD) is a common autoimmune disease (AID) that shares many of its susceptibility loci with other AIDs. The thyroid stimulating hormone receptor (TSHR) represents the primary autoantigen in GD, in which autoantibodies bind to the receptor and mimic its ligand, thyroid stimulating hormone, causing the characteristic clinical phenotype. Although early studies investigating the TSHR and GD proved inconclusive, more recently we provided convincing evidence for association of the TSHR region with disease. In the current study, we investigated a combined panel of 98 SNPs, including 70 tag SNPs, across an extended 800 kb region of the TSHR to refine association in a cohort of 768 GD subjects and 768 matched controls. In total, 28 SNPs revealed association with GD (P < 0.05), with strongest SNP associations at rs179247 (chi(2) = 32.45, P = 8.90 x 10(-8), OR = 1.53, 95% CI = 1.32-1.78) and rs12101255 (chi(2) = 30.91, P = 1.95 x 10(-7), OR = 1.55, 95% CI = 1.33-1.81), both located in intron 1 of the TSHR. Association of the most associated SNP, rs179247, was replicated in 303 GD families (P = 7.8 x 10(-4)). In addition, we provide preliminary evidence that the disease-associated genotypes of rs179247 (AA) and rs12101255 (TT) show reduced mRNA expression ratios of flTSHR relative to two alternate TSHR mRNA splice variants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244275     DOI: 10.1093/hmg/ddp087

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

1.  Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study.

Authors:  Paul R Newby; Oliver J Pickles; Samaresh Mazumdar; Oliver J Brand; Jaqueline D Carr-Smith; Simon H S Pearce; Jayne A Franklyn; David M Evans; Matthew J Simmonds; Stephen C L Gough
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

Review 2.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

3.  Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.

Authors:  Eric M Jacobson; Heyi Yang; Francesca Menconi; Rong Wang; Roman Osman; Luce Skrabanek; Cheuk Wun Li; Mohammed Fadlalla; Alisha Gandhi; Vijaya Chaturvedi; Eric P Smith; Sandy Schwemberger; Andrew Osterburg; George F Babcock; Yaron Tomer
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

4.  A genome-wide association study identifies two new risk loci for Graves' disease.

Authors:  Xun Chu; Chun-Ming Pan; Shuang-Xia Zhao; Jun Liang; Guan-Qi Gao; Xiao-Mei Zhang; Guo-Yue Yuan; Chang-Gui Li; Li-Qiong Xue; Min Shen; Wei Liu; Fang Xie; Shao-Ying Yang; Hai-Feng Wang; Jing-Yi Shi; Wei-Wei Sun; Wen-Hua Du; Chun-Lin Zuo; Jin-Xiu Shi; Bing-Li Liu; Cui-Cui Guo; Ming Zhan; Zhao-Hui Gu; Xiao-Na Zhang; Fei Sun; Zhi-Quan Wang; Zhi-Yi Song; Cai-Yan Zou; Wei-Hua Sun; Ting Guo; Huang-Ming Cao; Jun-Hua Ma; Bing Han; Ping Li; He Jiang; Qiu-Hua Huang; Liming Liang; Li-Bin Liu; Gang Chen; Qing Su; Yong-De Peng; Jia-Jun Zhao; Guang Ning; Zhu Chen; Jia-Lun Chen; Sai-Juan Chen; Wei Huang; Huai-Dong Song
Journal:  Nat Genet       Date:  2011-08-14       Impact factor: 38.330

Review 5.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

6.  Genetic-epigenetic dysregulation of thymic TSH receptor gene expression triggers thyroid autoimmunity.

Authors:  Mihaela Stefan; Chengguo Wei; Angela Lombardi; Cheuk Wun Li; Erlinda S Concepcion; William B Inabnet; Randall Owen; Weijia Zhang; Yaron Tomer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-13       Impact factor: 11.205

7.  Association of polymorphisms of rs179247 and rs12101255 in thyroid stimulating hormone receptor intron 1 with an increased risk of Graves' disease: A meta-analysis.

Authors:  Jing Gong; Shu-Jun Jiang; Ding-Kun Wang; Hui Dong; Guang Chen; Ke Fang; Jin-Rui Cui; Fu-Er Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 8.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

9.  Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study.

Authors:  Alina Kurylowicz; Piotr Miśkiewicz; Ewa Bar-Andziak; Janusz Nauman; Tomasz Bednarczuk
Journal:  Thyroid Res       Date:  2009-11-03

10.  Association of the CTLA4 gene with Graves' disease in the Chinese Han population.

Authors:  Shuang-Xia Zhao; Chun-Ming Pan; Huang-Ming Cao; Bing Han; Jing-Yi Shi; Jun Liang; Guan-Qi Gao; Yong-De Peng; Qing Su; Jia-Lun Chen; Jia-Jun Zhao; Huai-Dong Song
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.